Abbott Laboratories (ABT)
After hours: 04:42PM EDT
Chart Events
Performance Outlook
| Previous Close | 125.13 |
| Open | 125.50 |
| Bid | 124.80 x 800 |
| Ask | 124.81 x 900 |
| Day's Range | 124.18 - 125.74 |
| 52 Week Range | 100.34 - 129.70 |
| Volume | 6,067,408 |
| Avg. Volume | 4,739,760 |
| Market Cap | 220.982B |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 35.11 |
| EPS (TTM) | 3.55 |
| Earnings Date | Oct 19, 2021 - Oct 25, 2021 |
| Forward Dividend & Yield | 1.80 (1.44%) |
| Ex-Dividend Date | Oct 14, 2021 |
| 1y Target Est | 132.05 |
Fair Value
Related Research
- Abbott LaboratoriesAnalyst Report: Abbott LaboratoriesAbbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.RatingFair ValueEconomic MoatyesterdayMorningstar
- Reuters
U.S. government to buy point-of-care COVID-19 tests from Abbott, Celltrion -source
The U.S. government has agreed to purchase point-of care COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of its broader plan to purchase $2 billion in rapid coronavirus tests, a person familiar with the matter said on Tuesday. The federal government will purchase tests as needed and has agreed to spend up to $626 million in its agreement with Celltrion and $554.4 million in its deal with Abbott, the person said.
- Zacks
Abbott's (ABT) Portico With FlexNav System Gets FDA Approval
Abbott's (ABT) Portico with FlexNav TAVR system is intended to treat people with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery.
- MarketWatch
Elon Musk chips in $50 million for SpaceX Inspiration4’s children’s cancer fundraising effort
Billionaire Jared Isaacman, who paid for the SpaceX Inspiration4 flight, pledged $100 million St. Jude Children's Research Hospital and set a goal of raising an additional $100 million by February 2022.
